Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
$7.57
+4.8%
$7.57
$3.68
$8.85
$282.63M0.65215,430 shs76,883 shs
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
$18.02
-0.7%
$17.69
$4.66
$34.05
$70.42M1.66134,027 shs668,819 shs
OpGen, Inc. stock logo
OPGN
OpGen
$0.00
$3.07
$0.00
$0.00
$1K-1.771,028 shs156 shs
The Beauty Health Company stock logo
SKIN
Beauty Health
$2.22
+7.0%
$1.88
$0.78
$2.56
$280.91M1.2853,177 shs708,331 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
-0.28%-2.70%-2.96%+7.44%+26.44%
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
+1.85%-3.77%+8.04%+32.70%+15.54%
OpGen, Inc. stock logo
OPGN
OpGen
0.00%0.00%-100.00%-100.00%-100.00%
The Beauty Health Company stock logo
SKIN
Beauty Health
-2.36%-4.61%+13.11%+28.57%+30.19%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
0.8181 of 5 stars
1.30.00.00.01.94.20.6
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
OpGen, Inc. stock logo
OPGN
OpGen
N/AN/AN/AN/AN/AN/AN/AN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
1.0462 of 5 stars
2.00.00.00.02.83.30.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
2.50
Moderate Buy$8.005.74% Upside
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
0.00
N/AN/AN/A
OpGen, Inc. stock logo
OPGN
OpGen
0.00
N/AN/AN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
2.00
Hold$2.6318.51% Upside

Current Analyst Ratings Breakdown

Latest MGEN, OPGN, SKIN, and LFCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/1/2025
The Beauty Health Company stock logo
SKIN
Beauty Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$3.00 ➝ $4.00
(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
$128.87M2.20N/AN/A$0.04 per share189.15
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
$4.46M15.79N/AN/A$6.78 per share2.66
OpGen, Inc. stock logo
OPGN
OpGen
$2.67M0.00N/AN/A($11.55) per share0.00
The Beauty Health Company stock logo
SKIN
Beauty Health
$334.30M0.84$0.07 per share33.53$0.58 per share3.82
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
-$38.72M-$1.31N/AN/AN/A-31.70%-846.51%-13.03%10/3/2025 (Estimated)
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
-$41.87M-$20.09N/AN/AN/A-1,393.50%-141.66%-88.74%N/A
OpGen, Inc. stock logo
OPGN
OpGen
-$32.67MN/A0.00N/A-1,140.36%N/A-287.58%N/A
The Beauty Health Company stock logo
SKIN
Beauty Health
-$29.10M-$0.28N/AN/AN/A-6.13%-32.82%-2.96%N/A

Latest MGEN, OPGN, SKIN, and LFCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/25/2025Q4 2025
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
-$0.09N/AN/AN/A$35.36 millionN/A
8/7/2025Q4 2025
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
-$0.09-$0.10-$0.01-$0.06$35.36 million$36.44 million
8/7/2025Q2 2025
The Beauty Health Company stock logo
SKIN
Beauty Health
-$0.06$0.03+$0.09$0.03$74.67 million$78.20 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
N/AN/AN/AN/AN/A
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
N/AN/AN/AN/AN/A
OpGen, Inc. stock logo
OPGN
OpGen
N/AN/AN/AN/AN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
113.76
2.84
1.77
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
0.20
4.23
4.23
OpGen, Inc. stock logo
OPGN
OpGen
N/A
5.45
5.45
The Beauty Health Company stock logo
SKIN
Beauty Health
4.91
5.15
4.15

Institutional Ownership

CompanyInstitutional Ownership
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
83.36%
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
N/A
OpGen, Inc. stock logo
OPGN
OpGen
2.68%
The Beauty Health Company stock logo
SKIN
Beauty Health
93.26%

Insider Ownership

CompanyInsider Ownership
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
32.20%
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
1.10%
OpGen, Inc. stock logo
OPGN
OpGen
43.80%
The Beauty Health Company stock logo
SKIN
Beauty Health
41.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
69037.41 million25.36 millionOptionable
Miragen Therapeutics, Inc. stock logo
MGEN
Miragen Therapeutics
453.91 millionN/ANot Optionable
OpGen, Inc. stock logo
OPGN
OpGen
10010.07 million4.70 millionNot Optionable
The Beauty Health Company stock logo
SKIN
Beauty Health
1,030126.82 million74.83 millionOptionable

Recent News About These Companies

10 Best Natural Oils for Healthy, Glowing Skin
How to Get Glass Skin Like a K-Beauty Expert
Ancient beauty secrets find place in modern skincare
Nu You Med Spa Blends Beauty and Wellness for Total Transformation
Travel tips: 10 beauty and skincare hack you must know

New MarketBeat Followers Over Time

Media Sentiment Over Time

Lifecore Biomedical stock logo

Lifecore Biomedical NASDAQ:LFCR

$7.57 +0.35 (+4.79%)
As of 03:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Miragen Therapeutics stock logo

Miragen Therapeutics NASDAQ:MGEN

Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high-unmet medical need. Its four lead product candidates include cobomarsen, an inhibitor of miR-155 for treating various blood cancers, such as cutaneous T-cell lymphoma, adult T-cell lymphoma/leukemia, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia; Remlarsen, a replacement for miR-29, a microRNA that is found at abnormally low levels in various pathological fibrotic conditions, including cutaneous and ocular fibrosis, which is in Phase II clinical trial; MRG-229, which is in preclinical trial for the treatment of idiopathic pulmonary fibrosis; and MRG- 110, an inhibitor of miR-92, a microRNA expressed in endothelial cells, which has completed two Phase I clinical trial for the treatment of heart failure, wound healing, and other ischemic disease in the United States and Japan. Miragen Therapeutics, Inc. was founded in 2006 and is based in Boulder, Colorado.

OpGen stock logo

OpGen NASDAQ:OPGN

$0.0001 0.00 (0.00%)
As of 11:49 AM Eastern

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.

Beauty Health stock logo

Beauty Health NASDAQ:SKIN

$2.22 +0.15 (+7.00%)
As of 03:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.